{"id":"W2795076534","doi":"10.1016/j.blre.2018.03.006","title":"Time to repeal and replace response criteria for acute myeloid leukemia?","year":2018,"lang":"en","type":"review","venue":"Blood Reviews","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Bristol-Myers Squibb; Agios Pharmaceuticals; Celgene; Daiichi-Sankyo; Pfizer; Amgen","keywords":"Medicine; Clinical trial; Intensive care medicine; Minimal residual disease; Myeloid leukemia; Oncology; Disease; Immunology; Internal medicine; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.007556249,0.001070481,0.006313758,0.0005987848,0.0002124523,0.0001161458,0.0006839803,0.0008014385,0.001122282],"category_scores_gemma":[0.005787355,0.0007574797,0.001265892,0.0008569985,0.0002662663,0.000108718,0.0006176663,0.0008744226,0.005753465],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007413786,"about_ca_system_score_gemma":0.00256184,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006834846,"about_ca_topic_score_gemma":0.000001215198,"domain_scores_codex":[0.9930212,0.001515921,0.002111564,0.001820378,0.0004894186,0.001041481],"domain_scores_gemma":[0.9943541,0.00102111,0.000705791,0.00263176,0.00033805,0.0009491319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009359078,0.0000489829,1.131617e-7,0.0292379,0.0006602999,0.0001510574,0.0000801859,1.601562e-9,0.000122498,0.00000278886,0.4504498,0.5183105],"study_design_scores_gemma":[0.001449457,0.00172562,9.28235e-7,0.03833685,0.009266444,0.002927814,0.000004760241,0.000005163195,0.00002647853,0.000003128972,0.9455981,0.0006553064],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000048327,0.9832003,0.00003167171,0.0006074523,0.0001881156,0.01392106,0.0003303893,0.0001368056,0.001535927],"genre_scores_gemma":[2.430141e-8,0.8940704,0.01404389,0.001061242,0.001530875,0.00247264,0.0003530961,0.0002637965,0.08620404],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5176552,"threshold_uncertainty_score":0.9997908,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07172630987163685,"score_gpt":0.4155518578424391,"score_spread":0.3438255479708022,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}